4cra: Difference between revisions
Jump to navigation
Jump to search
m Protected "4cra" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
The entry 4cra is ON HOLD | The entry 4cra is ON HOLD until Paper Publication | ||
Authors: Sandmark, J., Oster, L., Fjellstrom, O., Akkaya, S., Beisel, H.G., Eriksson, P.O., Erixon, K., Gustafsson, D., Jurva, U., Kang, D., Karis, D., Knecht, W., Nerme, V., Nilsson, I., Olsson, T., Redzic, A., Roth, R., Tigerstrom, A. | Authors: Sandmark, J., Oster, L., Fjellstrom, O., Akkaya, S., Beisel, H.G., Eriksson, P.O., Erixon, K., Gustafsson, D., Jurva, U., Kang, D., Karis, D., Knecht, W., Nerme, V., Nilsson, I., Olsson, T., Redzic, A., Roth, R., Tigerstrom, A. | ||
Description: Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design | Description: Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design | ||
Revision as of 10:04, 13 August 2014
Unreleased structure
The entry 4cra is ON HOLD until Paper Publication
Authors: Sandmark, J., Oster, L., Fjellstrom, O., Akkaya, S., Beisel, H.G., Eriksson, P.O., Erixon, K., Gustafsson, D., Jurva, U., Kang, D., Karis, D., Knecht, W., Nerme, V., Nilsson, I., Olsson, T., Redzic, A., Roth, R., Tigerstrom, A.
Description: Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design